CPC
ADPT icon

Cookson Peirce & Co’s Adaptive Biotechnologies ADPT Stock Holding History

Cookson Peirce & Co’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$868K Buy
+40,449
New +$620K 0.03% 217
2026
Q1 		– Sell
-105,689
Closed -$1.72M – 304
2025
Q4 		$1.72M Buy
+105,689
New +$1.72M 0.07% 122
2025
Q3 		– Sell
-45,000
Closed -$524K – 307
2025
Q2 		$524K Buy
+45,000
New +$409K 0.02% 225

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cookson Peirce & Co's ADPT Position: Q2 2026 in Review

Cookson Peirce & Co opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 40,449 shares worth $868K. The stake represents 0.03% of the portfolio and ranks #217 among its holdings. This is a return to the name: Cookson Peirce & Co previously reported a position in ADPT as recently as Q4 2025.

Cookson Peirce & Co first reported a position in ADPT in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.72M in Q4 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Cookson Peirce & Co held 40,449 shares of Adaptive Biotechnologies worth $868K as of Q2 2026.
  • Adaptive Biotechnologies was a new Cookson Peirce & Co position in Q2 2026.
  • Adaptive Biotechnologies made up 0.03% of Cookson Peirce & Co's portfolio in Q2 2026, its #217 holding.
  • Cookson Peirce & Co first reported a position in Adaptive Biotechnologies in Q2 2025 and has held it in 3 quarters since.
  • Cookson Peirce & Co's Adaptive Biotechnologies position peaked at $1.72M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.